GENE ONLINE|News &
Opinion
Blog

2025-12-01|

Bacillus and Pseudomonas Studied as Biocontrol Agents Against Fusarium Wilt in Ethiopian Chili Pepper Crops

by GOAI
Share To

Researchers have investigated the potential of Bacillus and Pseudomonas bacterial genera as biocontrol agents against Fusarium oxysporum, a pathogen known to cause wilt disease in chili pepper crops. The study, conducted by Yilma, Tadesse, and Alemu, examines the effectiveness of these bacteria in managing the disease, which poses a significant threat to chili pepper production in Ethiopia. The findings aim to contribute to sustainable agricultural practices by exploring biological alternatives to chemical pesticides.

The research highlights how Bacillus and Pseudomonas exhibit properties that can suppress Fusarium oxysporum. These bacteria are known for their ability to produce antimicrobial compounds and promote plant health. The study focuses on their application in chili pepper cultivation, where Fusarium wilt has caused substantial crop losses. By leveraging these naturally occurring microorganisms, the researchers aim to provide an environmentally friendly solution for farmers facing challenges from this persistent pathogen.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 1, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top